Shanghai Xuhui District Central Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Shanghai China (1934)

Organization Overview

First Clinical Trial
2013
NCT02017236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Shanghai Xuhui Center hospital | Shanghai Xuhui District Central Hospital | Xuhui Center Hospital | Xuhui Center Hospital, Shanghai | Xuhui Central Hospital, Shanghai | XuHui District Central Hospital | Xuzhou Central Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 4)

Carcinoma, Squamous Cell (Phase 4)

Cholangiocarcinoma (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus, Type 2 (Phase 1)

Fever (Phase 2)

Head and Neck Neoplasms (Phase 2)

Heart Diseases (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Recurrence (Phase 2)

Schizophrenia (Phase 1)

ST Elevation Myocardial Infarction (Phase 4)

Urolithiasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial APIs: 34